Thomas J. Schall
2015
In 2015, Thomas J. Schall earned a total compensation of $2.9M as President and Chief Executive Officer at ChemoCentryx, a 11% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $228,580 |
|---|---|
| Option Awards | $2,117,514 |
| Salary | $571,450 |
| Other | $1,290 |
| Total | $2,918,834 |
Schall received $2.1M in option awards, accounting for 73% of the total pay in 2015.
Schall also received $228.6K in non-equity incentive plan, $571.5K in salary and $1.3K in other compensation.
Rankings
In 2015, Thomas J. Schall's compensation ranked 3,269th out of 13,638 executives tracked by ExecPay. In other words, Schall earned more than 76.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,269 out of 13,638 | 76th |
Division Manufacturing | 1,185 out of 5,190 | 77th |
Major group Chemicals And Allied Products | 431 out of 1,854 | 77th |
Industry group Drugs | 341 out of 1,528 | 78th |
Industry Pharmaceutical Preparations | 273 out of 1,182 | 77th |
Source: SEC filing on April 10, 2017.
Schall's colleagues
We found two more compensation records of executives who worked with Thomas J. Schall at ChemoCentryx in 2015.